Drug Profile
Research programme: 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors - vTv Therapeutics
Alternative Names: HPP 851Latest Information Update: 27 Jan 2016
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Developer TransTech Pharma; vTv Therapeutics LLC
- Class Small molecules
- Mechanism of Action 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Glaucoma; Metabolic disorders
Most Recent Events
- 27 Jan 2016 Discontinued - Preclinical for Glaucoma in USA (Ophthalmic)
- 21 Sep 2010 Discontinued - Preclinical for Metabolic disorders in USA (unspecified route)
- 26 Jan 2008 Preclinical trials in Metabolic disorders in USA (unspecified route)